Skip navigation Consumer Fund Healthcare Info & Comm Technology Internet & Digital Media

Codon Devices

Codon Devices is a privately-held biotechnology company focused on enabling commercial applications of synthetic biology. Codon Devices' proprietary synthesis and design technologies improve the productivity, throughput and flexibility of its industrial, pharmaceutical and academic customers in a paradigm shift to what the company calls Constructive Biology™. The company's focus is on developing and delivering high-value products and design services in a variety of application areas, including engineered gene libraries, engineered cells that produce novel pharmaceuticals, improved vaccines, agricultural products, and biorefineries for the production of industrial chemicals and energy.

Codon Devices' BioFAB™ platform uses sophisticated informatics, robotics and sequencing technologies to accurately synthesize genetic codes orders of magnitude more rapidly and cost-effectively than other currently available technology. Codon Devices is currently scaling the platform to design and construct engineered genetic devices hundreds of kilobases to megabases in length.

Recent News

Codon Devices and Algenol Biofuels Announce Partnership for Development of Biofuels from Algae

Codon Devices Names Kareem Saad to Vice President, Marketing and Business Development

Codon Devices and Merrimack Pharmaceuticals Enter Into Research, Development and License Agreement

Codon Devices Secures $11 Million in Series B Financing

Codon Devices Awarded $1.5 Million Grant by National Institute of Standards and Technology

Codon Devices Announces Appointment of Brian M. Baynes as President

Codon Devices Expands Gene Scaffolding Reach